VincentD’AndreaMD

PubMed

• 7 citations
  Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Pros...
  E. Gogineni, Z.H. Rana, Danielle Soberman, Baho Sidiqi, Vincent D'Andrea
  International Journal of Radiation Oncology, Biology, Physics. 2021-04-01
• 29 citations
  The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.
  Dawid G. Nowak, Ksenya Cohen Katsenelson, Kaitlin Watrud, Muhan Chen, Grinu Mathew
  The Journal of Cell Biology. 2019-06-03

Journal Articles

• Chemical Inhibitors of a Selective SWI/SNF Function Synergize with ATR Inhibition in Cancer Cell Killing  
  Chory EJ, Kirkland JG, Chang CY, D’Andrea VD, Gourisanker S, Dykhuizen EC, Crabtree GR, ACS Chem. Biol., 5/5/2020
• Salvage Brachytherapy for Recurrent Prostate Cancer after Definitive Radiation Treatment and Factors That May Impact Outcomes  
  Rana ZH, D’Andrea V, Cox BW, Potters L, International Journal of Radiation Oncology, 9/1/2019
• Extensive Pelvic Lymphatic Malformations Presenting with Hematospermia  
  Nethala D, Morganstern B, D’Andrea V, Fine R, Journal of Pediatric Urology Case Reports, 7/1/2019
• Inhibition of a Selective SWI/SNF Function Synergizes with ATR Inhibitors in Cancer Cell Killing  
  Chory EJ, Kirkland JG, Chang CY, D’Andrea VD, Gourinsankar S, Dykhuizen EC, Crabtree GR, BioRxiv, 6/4/2019
• The PHLPP2 phosphatase is a druggable driver of prostate cancer progression  
  Nowak D, Cohen-Katsenelson K, Watrud K, Mathew G, D’Andrea V, Lee M, Swamynathan M, Salas I, Jibilian M, Buckholtz C, Ambrico A, Chen M, Pan CH, Wilkinson J, Newton A,..., Journal of Cell Biology, 5/15/2019
• A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation  
  Berendsen TA, Bruinsma BB, Lee J, D’Andrea V, Liu Q, Izamis M, Uygun K, Yarmush ML, Transplantation Research, 5/9/2012
• Join now to see all

Books/Book Chapters

• StatPearls 
  Chapter: Nocturia 
  Leslie SW, D’Andrea VD, Singh S2019

Abstracts/Posters

• Salvage Brachytherapy for Recurrent Prostate Cancer after Definitive Radiation Treatment and Factors That May Impact Outcomes
  Rana Z, D’Andrea V, Cox B, Lee L, Potters L, American Society for Radiation Oncology (ASTRO) Annual Meeting, Chicago, IL, 9/16/2019
• Outcomes and Toxicity Following Salvage Low-Dose-Rate Brachytherapy for Recurrent Prostate Cancer after Radiation Therapy
  D’Andrea V, Rana Z, Cox B, Potters L, American Brachytherapy Society (ABS) Annual Meeting, Miami, FL, 6/14/2019
• Phlpp2 is a druggable driver of Myc in metastatic prostate cancer
  D’Andrea V, Nowak DG, Trotman, L, iCancer 3rd International Cancer Conference and Expo, Baltimore, MD, 6/5/2019
• Extensive Pelvic Lymphatic Malformations Presenting with Hematospermia
  D’Andrea V, Nethala D, Morganstern B, Fine R, Northwell Academic Competition, Hempstead, NY, 5/20/2019
• To biopsy or not to biopsy, that is the question: Risk stratification of patients with negative MRI
  Perez-Orozco A, Wood A, Rabinowitz D, Marziliano A, Torres J, Ng T, Chacko N, D’Andrea V, Griffiths L, Kotamarti S, Vilaro J, Diefenbach M, Vira M, Hall S, American Urological Association Annual Meeting, Chicago, IL, 5/4/2019
• The Phlpp2 phosphatase protects Myc and is a target for the prevention of prostate cancer metastasis
  D'Andrea V, Nowak D, Watrud K, Ambrico A, Casanova-Salas I, Trotman L, AACR Annual Meeting 2018, Chicago, IL, 4/16/2018
• Join now to see all